stem cell image

An innovative, Cell Therapy based CDMO Announces the Expansion of its Facility

Lykan Bioscience, a contract development and manufacturing organisation specialising in cell-based therapeutics, announced the expansion of its facility in Hopkinton, Massachusetts. The increasing need for cell therapy process research and production is driving the expansion and establishment of new innovation lab. As part of the facility
expansion plan, seven ISO 7 cGMP suites with autologous and allogeneic production capabilities will be added to the current facility, bringing the total of clinical and commercial cGMP manufacturing suites to 15.

Company’s manufacturing capabilities will be expanded by 1,700 square feet to support partner initiatives and CMC innovation. The laboratory extension should be commissioned and ready for customer projects by Q4 2021.

Source: Lykan Bioscience, 9th November 2021

IMAPAC’s unique and one-of-a-kind tracker, “APAC – CELL & GENE THERAPY TRACKER,” provides an extensive coverage for 150+ Cell & Gene Therapy Manufacturing Facilities. IMAPAC hopes to provide essential information on the ongoing Cell & Gene Therapy Pipeline and Manufacturing Facilities in the Asia-Pacific Region with this tracker. Please contact us at info@imapac.com to learn more about this tracker. A detailed prospectus for this tracker is available upon request.

Comments

Leave A Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

bag